Medical device manufacturers are currently focusing on development of cellular-electrode interface and the employment of organic conductors as alternative to metal electrodes. Organic conductors possess excellent electrical properties such as unfettered conductivity and reduced impedance to start the power system. They also possess high malleability in order to fabricate them as effective medical devices. Organic conductors must also have specific chemical properties such as hydrophilicity, biocompatibility and thermostability to undergo sterilization without degradation of the above properties.
The products segmentation of this study comprises of heart bionics, orthopedic bionics, ear bionics, vision bionics and neural bionics. The application segments include implantable bionics and external bionics. Data forecast and market assessment for the duration 2019 to 2029 are covered in the scope of the report.
5 major geographical regions with their respective major countries are covered in the medical bionics geography segment:
Data forecasting and CAGR for the geographic segmentation are covered in the scope of the report.
Product portfolio exhibits the diverse range of medical bionics available with the key players with their application for different disease conditions such as cardiac, neural, vision etc. Latest news coverage gives brief information regarding the latest upgrading happening in the integral circuit design of implantable bionics, mergers and acquisitions between research institutes and medical device manufacturers. This market assessment is an important tool utilized for mapping the latest trends prevalent in the medical bionics market supplementing them with market size and CAGR. Porter’s five forces model is included in the study to understand the competitive nature prevalent in the medical bionics market. The market leaders of medical bionics market are Boston Scientific Corporation, BionX Medical Technologies, Inc., Cochlear Ltd., Edward Lifesciences Corporation, Ekso Bionics, LifeNet Health Inc., Medtronic Plc., Ossur, Second Sight Medical Products, Inc., and St. Jude Medical, Inc.
Based on product, the medical bionics market is categorized into:
The transfer of technology between artificially created objects and living cells is called as bionics, and the field is currently having huge application in medical science. Bionics is further segregated into various disciplines such as structural bionics, processing bionics and information bionics, subject to their specific applications. Based on product types, heart bionics is currently dominating the products segment owing to the rising prevalence of cardiac complications such as arrhythmias, valvular stenosis and congenital heart disease. Affordable reimbursement scenario for heart bionics motivates people to undergo surgical procedures for such implants. Ear bionics for e.g. Cochlear™ Nucleus® Kanso® manufactured by Cochlear, Ltd., have a tremendous potential for market growth in the near future due to rising prevalence of otitis media and conductive hearing loss due to otosclerosis. The market leaders of medical bionics market are Boston Scientific Corporation, BionX Medical Technologies, Inc., Cochlear Ltd., Edward Lifesciences Corporation, Ekso Bionics, LifeNet Health Inc., Medtronic Plc., Ossur, Second Sight Medical Products, Inc., and St. Jude Medical, Inc.
Based on applications, the medical bionics market is categorized into:
Medical bionics has a potential future in the life sciences industry. The major challenges faced by the medical bionics market mainly comprise the lack of commercialization of bionic products and hence they are not being prescribed by physicians for treating chronic ailments. Manufacturers are looking into qualities such as hermetic encapsulation of bionic implants to protect the circuit elements of the device form the body solutions. Neural bionics manufacturers are using novel conductive polymers and micromachining approaches to create neural interfaces to deliver electrical impulses to the nervous system. Tissue contacting materials such as silicon polymers are utilized in bionic implants to meet the biocompatibility aspects and interaction with the surrounding biological environment. Implantable bionics currently leads the applications segment due to its favorable features such as biocompatibility, mechanical stability, and corrosion resistance favoring long-term therapy for chronic ailments. External bionics is set to grow at a rapid pace on account of increasing number of accidents leading to limb amputations and the evolution in ergonomic design of external bionics making them easy to handle and operate.
For the purpose of this study, the global medical bionics market is categorized into the following regional and country specific markets:
The Center for Disease Control and Prevention 2014 report states that 7 out of 10 causes of death in the United States were chronic diseases majorly comprising of lifestyle disorders. North America is the leader in medical bionics market owing growing demand for these products on the grounds of rising prevalence of chronic diseases and existence of developed healthcare infrastructure. Technological development in the nature of implantable bionics regarding the integrated device circuits propels the North America market growth. The growth of European market is driven by the supportive regulatory environment provided by the European Medical Agency for medical devices approval. Eastern European region serves as a lucrative market attributed by developing healthcare infrastructure and establishment of subsidiaries of key players engaged in production of medical bionics. Asia Pacific will be registering excellent growth during the forecast period due to huge patient pool suffering with chronic diseases. Emergence of domestic players manufacturing medical bionics has created a competitive market for the market leaders, which has a positive influence on the market growth of medical bionics in Asia Pacific
This product will be delivered within 2 business days.
The products segmentation of this study comprises of heart bionics, orthopedic bionics, ear bionics, vision bionics and neural bionics. The application segments include implantable bionics and external bionics. Data forecast and market assessment for the duration 2019 to 2029 are covered in the scope of the report.
5 major geographical regions with their respective major countries are covered in the medical bionics geography segment:
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- Rest of Europe
- Asia Pacific
- China
- Japan
- Rest of Asia Pacific
- Latin America
- Mexico
- Brazil
- Rest of LATAM
- Middle East and Africa
- GCC
- Rest of Middle East and Africa
Data forecasting and CAGR for the geographic segmentation are covered in the scope of the report.
Product portfolio exhibits the diverse range of medical bionics available with the key players with their application for different disease conditions such as cardiac, neural, vision etc. Latest news coverage gives brief information regarding the latest upgrading happening in the integral circuit design of implantable bionics, mergers and acquisitions between research institutes and medical device manufacturers. This market assessment is an important tool utilized for mapping the latest trends prevalent in the medical bionics market supplementing them with market size and CAGR. Porter’s five forces model is included in the study to understand the competitive nature prevalent in the medical bionics market. The market leaders of medical bionics market are Boston Scientific Corporation, BionX Medical Technologies, Inc., Cochlear Ltd., Edward Lifesciences Corporation, Ekso Bionics, LifeNet Health Inc., Medtronic Plc., Ossur, Second Sight Medical Products, Inc., and St. Jude Medical, Inc.
Based on product, the medical bionics market is categorized into:
- Heart Bionics
- Orthopedic Bionics
- Ear Bionics
- Vision Bionics
- Neural Bionics
The transfer of technology between artificially created objects and living cells is called as bionics, and the field is currently having huge application in medical science. Bionics is further segregated into various disciplines such as structural bionics, processing bionics and information bionics, subject to their specific applications. Based on product types, heart bionics is currently dominating the products segment owing to the rising prevalence of cardiac complications such as arrhythmias, valvular stenosis and congenital heart disease. Affordable reimbursement scenario for heart bionics motivates people to undergo surgical procedures for such implants. Ear bionics for e.g. Cochlear™ Nucleus® Kanso® manufactured by Cochlear, Ltd., have a tremendous potential for market growth in the near future due to rising prevalence of otitis media and conductive hearing loss due to otosclerosis. The market leaders of medical bionics market are Boston Scientific Corporation, BionX Medical Technologies, Inc., Cochlear Ltd., Edward Lifesciences Corporation, Ekso Bionics, LifeNet Health Inc., Medtronic Plc., Ossur, Second Sight Medical Products, Inc., and St. Jude Medical, Inc.
Based on applications, the medical bionics market is categorized into:
- Implantable Bionics
- External Bionics
Medical bionics has a potential future in the life sciences industry. The major challenges faced by the medical bionics market mainly comprise the lack of commercialization of bionic products and hence they are not being prescribed by physicians for treating chronic ailments. Manufacturers are looking into qualities such as hermetic encapsulation of bionic implants to protect the circuit elements of the device form the body solutions. Neural bionics manufacturers are using novel conductive polymers and micromachining approaches to create neural interfaces to deliver electrical impulses to the nervous system. Tissue contacting materials such as silicon polymers are utilized in bionic implants to meet the biocompatibility aspects and interaction with the surrounding biological environment. Implantable bionics currently leads the applications segment due to its favorable features such as biocompatibility, mechanical stability, and corrosion resistance favoring long-term therapy for chronic ailments. External bionics is set to grow at a rapid pace on account of increasing number of accidents leading to limb amputations and the evolution in ergonomic design of external bionics making them easy to handle and operate.
For the purpose of this study, the global medical bionics market is categorized into the following regional and country specific markets:
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East and Africa
- GCC
- Rest of Middle East and Africa
The Center for Disease Control and Prevention 2014 report states that 7 out of 10 causes of death in the United States were chronic diseases majorly comprising of lifestyle disorders. North America is the leader in medical bionics market owing growing demand for these products on the grounds of rising prevalence of chronic diseases and existence of developed healthcare infrastructure. Technological development in the nature of implantable bionics regarding the integrated device circuits propels the North America market growth. The growth of European market is driven by the supportive regulatory environment provided by the European Medical Agency for medical devices approval. Eastern European region serves as a lucrative market attributed by developing healthcare infrastructure and establishment of subsidiaries of key players engaged in production of medical bionics. Asia Pacific will be registering excellent growth during the forecast period due to huge patient pool suffering with chronic diseases. Emergence of domestic players manufacturing medical bionics has created a competitive market for the market leaders, which has a positive influence on the market growth of medical bionics in Asia Pacific
This product will be delivered within 2 business days.
Table of Contents
Chapter 1. Preface
Chapter 2. Executive Summary
Chapter 3. Medical Bionics Market: Dynamics and Future Outlook
Chapter 4. Global Medical Bionics Market, by Product, 2019 - 2029 (US$ Mn)
Chapter 5. Global Medical Bionics Market, by Application, 2019 - 2029 (US$ Mn)
Chapter 6. Global Medical Bionics Market, by Geography, 2019 - 2029 (US$ Mn)
Chapter 7. Company Profiles
Companies Mentioned
- Boston Scientific Corporation
- BionX Medical Technologies Inc.
- Cochlear Ltd.
- Edward Lifesciences Corporation
- Ekso Bionics
- LifeNet Health Inc.
- Medtronic Plc.
- Ossur
- Second Sight Medical Products Inc.
- St. Jude Medical Inc